옵션 체인은 다양한 행사가격과 만기일에 대한 Blade Air Mobility의 주식 옵션 주요 데이터를 보여줍니다. 트레이더들은 이 정보를 사용하여 잠재적 거래를 분석하고 Blade Air Mobility에 대한 시장 심리를 평가합니다..

Blade Air Mobility (NASDAQ:BLDE) 주식, 옵션 체인

Blade Air Mobility

Blade Air Mobility Inc is a technology-powered air mobility platform that provides air transportation and logistics for hospitals and is a transporter of human organs for transplant, and for passengers, with helicopter and fixed-wing services predominantly in the Northeast United States, Southern Europe and Western Canada. The company's operating segments are; Passenger, and Medical. Majority of the revenue for the company is generated from its Medical segment which predominantly consists of transportation of human organs for transplant and the medical teams supporting these services. It also offers additional services including donor logistics coordination and support in evaluating potential donor organs. A substantial portion of the company's revenue is generated from the United States.

Analyst Color

Previews

Analyst Ratings

Tech

Trading Ideas

ACHR

BLDE

JOBY

항공 모빌리티 기업들인 조비 항공(NYSE:JOBY), 아처 에비에이션(NYSE:ACHR) 그리고 블레이드 에어 모빌리티(NYSE:BLDE)의 분기 실적 발표 시즌이 시작되기 전이다.

항공 모빌리티 주식의 이륙 준비: 조비, 아처, 블레이드가 인증 및 자금 도전을 넘어 날아오를까?

Equities

News

Markets

ETFs

ARKK

AVAV

NTLA

TDOC

TSLA

VERV

수요일에 캐시 우드가 이끄는 아크 인베스트(Ark Invest)는 이 회사의 인상적인 2분기 납품 실적에 힘입은 최근 상승세에도 불구하고 테슬라(NASDAQ:TSLA)의 상당 수의 주식을 매각하여 주목할만한 움직임을 보였다.

아크 인베스트가 예상을 넘는 2분기 배송 실적에도 $3.25백만 규모 테슬라 주식 매도 추가

ADPT

ARKQ

PLTR

RXRX

월요일에 캐시 우드가 주도하는 아크 인베스트(Ark Invest)는 팔란티어 테크놀로지스(NYSE:PLTR)에 주목할 만한 투자를 했다. 이는 인공 지능(AI) 부문이 탄력을 받으면서 이루어진 움직임이다.

캐시 우드의 아크 인베스트는 AI 열풍 속에서 516만 달러 가치의 팔란티어 주식 매수

Blade Air Mobility, Inc. - Class A Common Stock

Blade Air Mobility Inc

WIIM

ROAD

Construction Partners shares are trading higher after the company raised its FY25 revenue guidance.

Addentax Group Corp. ("Addentax" or the "Company") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATXG#NASDAQ">ATXG</a>), an integrated service provider focusing on garment manufacturing, logistics services, property management, and subleasing, has announced the signing of a Memorandum of Understanding (MOU) for nationwide strategic cooperation with Shenzhen Yingbin Brand Development Co., Ltd. ("Yingbin Brand"), a prominent brand management company headquartered in Guangdong.

ATXG

Addentax Group Corp. Announces Signing Of MOU For Strategic Cooperation With Shenzhen Yingbin Brand Development Co., Ltd., Offering A Wide Range Of Services In Brand Supply Chain Management, Product Supply Chain Solutions, And Marketing Supply Chain Strategies

Maximus shares are trading lower after the company on Wednesday reported worse-than-expected Q4 adjusted EPS results.

iQIYI shares are trading lower despite a Q3 earnings beat.

RBC Capital analyst Pammi Bir maintains Riocan REIT (TSX:<a class="ticker" href="https://www.benzinga.com/stock/REI#TSX">REI</a>) with a Outperform and raises the price target from C$21 to C$22.

Price Target

TSX:REI

TSX:REI/UN

RBC Capital Maintains Outperform on Riocan REIT, Raises Price Target to C$22

On Wednesday, Pyxis Oncology, Inc.&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PYXS#NASDAQ">PYXS</a>) released preliminary data from the ongoing Phase 1 clinical dose escalation study evaluating PYX-201 in <a target="_blank" href="https://www.benzinga.com/pressreleases/24/11/g42099028/pyxis-oncology-announces-favorable-preliminary-pyx-201-clinical-phase-1-part-1-data" rel="noreferrer noopener">multiple solid tumors</a>.
Among evaluable Head and Neck Squamous Cell Carcinoma (HNSCC) patients treated at an identified dose range of PYX-201 from 3.6 – 5.4 mg/kg (n=6), a confirmed 50% objective response rate (ORR) was observed, including one confirmed complete response (CR) and two confirmed partial responses (PR).
The company additionally announced a Clinical Trial Collaboration Agreement with Merck &amp; Co Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MRK#NYSE">MRK</a>) for a Pyxis Oncology-sponsored study of PYX-201 in combination with Merck&#8217;s Keytruda (pembrolizumab) in patients with 1L and 2L HNSCC, HR+/HER2- breast cancer, and triple-negative breast cancer (TNBC) and sarcoma.
<ul>
<li>PYX-201 and Keytruda combination dose escalation and expansion study in 1L and 2L HNSCC with preliminary clinical data readout expected in the second half of 2025.</li>
<li>PYX-201 monotherapy study in 2L and 3L HNSCC patients who are platinum and PD-1 inhibitor experienced, with preliminary clinical data readout expected in the second half of 2025.</li>
<li>PYX-201 monotherapy study in 2L and 3L HNSCC patients who are EGFR and PD-1 inhibitor experienced, with preliminary clinical data readout expected in the first half of 2026.</li>
</ul>
Exploratory PYX-201 Phase 1 monotherapy expansion cohorts are planned for ovarian cancer, NSCLC, HR+/HER2 breast cancer, TNBC, and sarcoma. Preliminary clinical data are expected in the second half of 2025.
<ul>
<li>The company also expects to initiate the PYX-201 and Keytruda combination study in HR+/HER2 breast cancer, TNBC, and sarcoma, with preliminary clinical data expected in the second half of 2025 and the first half of 2026.</li>
<li>Preclinical studies of PYX-201 combined with other agents in ovarian cancer and NSCLC will commence in 2025, followed by clinical studies with preliminary clinical data expected in 2026.</li>
</ul>
PYX-201 demonstrated favorable preliminary tolerability profile data with low incidence of dose discontinuation, interruptions, or delays due to treatment-related adverse events.
William Blair analysts note that PYX-201 shows limited effectiveness outside of head-and-neck cancer, with only 8.7% of patients (2 out of 23) responding to tolerable doses of 3.6 mg/kg, 4.4 mg/kg, and 5.4 mg/kg.
&#8220;At this point, we are unsure whether the three unconfirmed responses could ultimately be confirmed,&#8221; the analysts writes.
The analysts has reduced the probability of success for PYX-201 to 10% from 35%. The updated fair value stands at $250 million or roughly $4.25 per share, comprising $1.77 per share from PYX-201 and $2.48 per share of cash.
With no major stock-moving events expected until the second half of 2025, the analysts estimate the stock will trade around $2.80 per share soon. William Blair says it includes $1.77 per share for PYX-201 and $1.07 for remaining cash by late 2025.
William Blair downgrades <a target="_blank" href="https://www.benzinga.com/quote/PYXS/analyst-ratings" rel="noreferrer noopener">Pyxis to Market Perform</a>, saying, &#8220;Since we view the head-and-neck cancer results as difficult to differentiate, coupled with modest activity in other solid tumor histologies.&#8221;
Price Action: PYXS stock is down 42.15% to $2.21 during premarket trading on Thursday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/price-target/24/11/42098028/qualcomms-shift-from-handsets-to-ai-and-automotive-wins-analysts-confidence" target="_blank" rel="noreferrer noopener">Qualcomm&#8217;s Shift From Handsets To AI And Automotive Wins Analysts&#8217; Confidence</a></li>
</ul>
Image created using artificial intelligence via Midjourney.

Biotech

Downgrades

Health Care

Movers

General

PYXS

Pyxis Oncology's Cancer Drug Progress Stirs Analyst Concerns

Contracts

SWVL

Swvl Signs Three-Year Contract With G4S In Saudi Arabia To Provide SaaS-Based Mobility Solutions, Enhancing Fleet Efficiency Across Riyadh, Jeddah, And Dammam With Over 14,000 Monthly Trips; Financial Terms Not Disclosed

NVDA

NVIDIA shares are trading higher following the company's Q3 earnings report.

Compass Point analyst Floris Van Dijkum upgrades Pebblebrook Hotel (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PEB#NYSE">PEB</a>) from Neutral to Buy and maintains the price target from $17 to $17.

Upgrades

Compass Point Upgrades Pebblebrook Hotel to Buy, Maintains Price Target to $17

RBC Capital analyst Pammi Bir maintains SmartCentres REIT (TSX:<a class="ticker" href="https://www.benzinga.com/stock/SRU#TSX">SRU</a>) with a Outperform and raises the price target from C$27 to C$28.

TSX:SRU

TSX:SRU/UN

RBC Capital Maintains Outperform on SmartCentres REIT, Raises Price Target to C$28

As of Nov. 21, 2024, two stocks in the energy sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
The RSI is a momentum indicator, which compares a stock&#8217;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#8217;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered overbought when the <a href="https://www.benzinga.com/topic/rsi">RSI is above 70</a>, according to <a href="https://pro.benzinga.com/">Benzinga Pro</a>. 
Here's the latest list of major overbought players in this sector.
<h3 class="wp-block-heading">Natural Gas Services Group, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NGS#NYSE">NGS</a>)</h3>
<ul>
<li>On Nov. 14, Natural Gas Services posted better-than-expected quarterly earnings. &#8220;We delivered another quarter of significant top and bottom-line growth, as well as a material increase in net cash provided by operating activities, as we further grow and optimize our business,&#8221; said Justin Jacobs, Chief Executive Officer. &#8220;Compression demand, particularly in the Permian Basin, remains robust. We continue to capitalize on our favorable industry position, innovative compression units, and strong customer relationships to increase investments in our large horsepower fleet as we look to drive growth in rental fleet horsepower, rental revenue, and cash flow.&#8221; The company's stock gained around 32% over the past month and has a <a href="https://www.benzinga.com/quote/NGS">52-week high of $26.00</a>.</li>
<li>RSI Value: 81.77&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li>
<li>NGS Price Action: Shares of Natural Gas Services closed at $25.91 on Wednesday.</li>
</ul>
<h3 class="wp-block-heading">Range Resources Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RRC#NYSE">RRC</a>)</h3>
<ul>
<li>On Oct. 22, the company posted better-than-expected quarterly earnings. Dennis Degner, the Company&#8217;s CEO, commented, &#8220;This month marks the 20th anniversary of Range drilling the first commercial Marcellus shale well. The Marcellus and Utica now produce nearly one-third of U.S. natural gas, and the U.S. has become the leading global supplier of safe, clean, affordable natural gas. We are tremendously proud of the role Range has played in this hugely impactful achievement and we are even more excited about what the future holds as global energy demand increases, improving the quality of life for billions of people living in energy poverty.&#8221; The company's stock gained around 17% over the past month and has a <a href="https://www.benzinga.com/quote/RRC">52-week high</a> of $39.33.</li>
<li>RSI Value: 76.05</li>
<li>RRC Price Action: Shares of Range Resources closed at $35.16 on Wednesday.</li>
</ul>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/24/11/42094434/top-3-consumer-stocks-that-are-ticking-portfolio-bombs">Top 3 Consumer Stocks That Are Ticking Portfolio Bombs</a></li>
</ul>

Short Ideas

Pre-Market Outlook

Top 2 Energy Stocks You May Want To Dump This Month

<ul>
<li>MSTR</li>
<li>NVDA</li>
<li>$BTC</li>
<li>CORN</li>
<li>MARA</li>
<li>COIN</li>
<li>SNOW</li>
<li>TSLA</li>
<li>AI</li>
<li>GLD</li>
</ul>
data from <a href="https://swaggystocks.com/dashboard/wallstreetbets/ticker-sentiment">https://swaggystocks.com/dashboard/wallstreetbets/ticker-sentiment</a>
&nbsp;

$BTC

COIN

CORN

MARA

MSTR

SNOW

Top 10 Trending Stocks On WallStreetBets As Of November 21, 2024 (Via Swaggy Stocks)

MULN

Mullen Automotive Prepares For Mid-2025 Launch Of US Battery Production, Expands Fullerton Facility With Additional High-Volume Battery Lines And Advanced R&D Capabilities To Support EV Innovation And Reduce Import Reliance

The 76,000-square-foot former Barnes &amp; Noble location has been empty for nearly two decades and is now under contract to Boston-based Hudson Group. According to the Boston Business Journal, citing sources familiar with the negotiations, the property is expected to sell for much less than its 2017 price tag of $63 million.
Don't Miss:
<ul>
<li>This Jeff Bezos-backed startup will allow you to <a href="https://www.benzinga.com/money/bezos-landlord-100-dollars">become a landlord in just 10 minutes, with minimum investments as low as $100 for properties like the Byer House from Stranger Things.</a></li>
<li>Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing —<a href="https://www.benzinga.com/money/boxabl"> you can become an investor for $0.80 per share today.</a></li>
</ul>
Brown, who signed a record-breaking $303.7 million contract last year, planned to transform the five-story building into a hub for Black entrepreneurship. His vision included featuring Black-owned businesses on the street level and housing his startup accelerator program on the upper floors.
"A building is a core part of BostonXchange, so he's looking forward to finding a location," Malia Lazu, Brown's consultant on the initiative, told the Boston Business Journal. The search continues for an alternative site downtown or elsewhere in the city.
The report said that the NBA All-Star&#8217;s interest represents exactly what civic leaders hope to see for vacant downtown properties in post-pandemic Boston. Michael Nichols, president of the Downtown Boston Business Improvement District, supported Brown&#8217;s mission. &#8220;We remain motivated to work with Jaylen and his team to find a space that can serve as the long-term epicenter for their mission-focused work,&#8221; Nichols said.
Trending: Invest in $20+ trillion home equity market today across cities like Austin, Miami, and Los Angeles through a <a href="https://www.benzinga.com/money/nada-cityfunds">unique 5-year term fund targeting a 14-20% IRR with minimums as low as $2,500</a>
The property&#8217;s troubled history extends beyond the pandemic. After Barnes &amp; Noble closed in 2006, it sat vacant until L3 Capital and LaSalle Investment Management purchased it in 2017. Despite millions in upgrades, COVID-19 derailed their plans, forcing them to surrender the building to lender Wells Fargo last year to avoid foreclosure, the report noted.
Hudson Group, the prospective buyer, brings experience in transforming downtown Boston properties. The firm has converted buildings in the Leather District into residential units and partnered with Brookfield on a 26-story apartment tower on the Greenway.
Brown&#8217;s initiative, Boston XChange, launched this summer and recently announced its first cohort of 10 businesses. While the Washington Street location didn&#8217;t work out, his broader mission to address Boston&#8217;s racial wealth gap through real estate and entrepreneurship continues.
The setback points to the ongoing challenges in major commercial <a href="https://www.benzinga.com/real-estate/24/11/41702735/millionaire-in-10-years-these-real-estate-markets-might-take-you-there">real estate</a> markets. Property values have declined sharply since the pandemic, creating obstacles and opportunities for innovative development projects. 
Read Next:
<ul>
<li>Unlock the hidden potential of commercial real estate —<a href="https://www.benzinga.com/money/marcus-millichap-backed-platform-makes-it-easy-to-invest-in-real-estate"> This platform allows individuals to invest in commercial real estate offering a 12% target yield with a bonus 1% return boost today!</a></li>
<li>Warren Buffett once said, "If you don't find a way to make money while you sleep, you will work until you die."<a href="https://www.benzinga.com/money/warren-buffet-make-money-when-you-sleep"> Here&#8217;s how you can earn passive income with just $100. </a></li>
</ul>

Real Estate

Jaylen Brown Takes A Shot At Downtown Boston Real Estate, Misses 399 Washington

<a href="https://www.globenewswire.com/Tracker?data=7hELYvsZhYCPCZZRxPvWFPXftOcrsR529q0BccXuyCnKPo0Eoy124Va-2XR6jPg5lSEgNiJULTo2kF8gqq3OLW235gewhBmVmSataxtiQbM=">Lumos Pharma, Inc.</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LUMO#NASDAQ">LUMO</a>), a clinical-stage biopharmaceutical company focused on therapeutics for rare diseases, announced that new analyses of data from its Phase 2 OraGrowtH210 and OraGrowtH212 clinical trials were presented orally at the <a href="https://www.globenewswire.com/Tracker?data=-kAJIm6iG1WBmRNwtlOVPPgHy3ST-VsJJJCqcM0zmevXz4rvwqE_vbVEwzbB0Yxipc_8dAs0TjYvUeSrDSvuIW1xcKSmhX2xa30Lg9ZcyZdvPQSiFvddVnL1YLSjeHDdRhQveDSqhDFvgWqa3NWE2rtGqKIhcfw1H6pT03o2laVM2Ak_lblI1TGslGc_Lhdu">62nd Annual European Society for Paediatric Endocrinology Meeting</a>, or ESPE 2024, held November 16-18, 2024 in Liverpool, UK.

LUMO

Lumos Pharma Presents Updated Phase 2 OraGrowtH Data Demonstrating Sustained Growth On Oral LUM-201 To 24 Months In PGHD And Correlation Of Growth To LUM-201's Unique Pulsatile Mechanism Of Action At ESPE 2024

BLEUU

Trading Halt: Halt status updated at 9:15:00 AM ET: Quotation Resumption: News and Resumption Times

NIO Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NIO#NYSE">NIO</a>), the Chinese electric vehicle (EV) maker, is seeing its shares trade lower in premarket trading on Thursday.
Macquarie analyst Eugene Hsiao downgraded the company&#8217;s rating from Outperform to Neutral and slashed the price target <a target="_blank" href="https://www.benzinga.com/quote/NIO/analyst-ratings" rel="noreferrer noopener">from $6.60 to $4.80.</a>
The downgrade follows a mixed fiscal third-quarter earnings report, which revealed a slight decline in year-over-year<a target="_blank" href="https://www.benzinga.com/news/earnings/24/11/42084907/nio-q3-earnings-11-6-gain-in-vehicle-deliveries-margins-improve-issues-robust-q4-delivery-outlook" rel="noreferrer noopener"> revenue and continued losses.</a>
NIO posted a revenue of 18.67 billion yuan ($2.66 billion) for the quarter, marking a 2.1% decrease from the same period in the previous year but an increase of 7.0% from the prior quarter. However, analysts had expected slightly higher revenue of $2.70 billion for the period.
Also Read: <a target="_blank" href="https://www.benzinga.com/24/11/42107863/us-futures-head-lower-as-nvidia-reports-slowdown-in-quarterly-revenue-growth-expert-says-market-weakness-is-perfectly-normal-but-late-november-is-still-possible" rel="noreferrer noopener">US Futures Head Lower As Nvidia Earnings Fail To Impress Investors: Expert Says Market Weakness Is &#8216;Perfectly Normal,&#8217; But Late November Rally Is Still Possible</a>
Excluding share-based compensation expenses, NIO reported an adjusted loss per share of 2.14 yuan, or a 31-cent loss, which was an improvement compared to the 2.28 yuan loss in the same quarter last year. Nonetheless, the company continues to struggle with narrowing its losses, though this quarter&#8217;s loss was slightly better than the 2.21 yuan loss seen in the second quarter of 2024.
Despite the disappointing financials, NIO executives have been actively unveiling new strategic developments.
The company shared details about its third EV brand, Firefly, which will officially launch on December 21, ahead of its parent company&#8217;s annual NIO Day event, reported <a target="_blank" href="https://cnevpost.com/2024/11/20/nio-officially-unveils-3rd-brand-firefly/" rel="noreferrer noopener">CnEV </a>Post. Firefly&#8217;s first model is expected to enter deliveries in the first half of 2025, a move seen as an effort to expand NIO&#8217;s presence in the competitive EV market.
Looking ahead, NIO has set a guidance of 72,000 to 75,000 vehicle deliveries for the fourth quarter, which represents a<a target="_blank" href="https://www.benzinga.com/calendars/guidance" rel="noreferrer noopener"> year-over-year increase of 43.9% to 49.9%</a>. The company also projects revenue for the fourth quarter in the range of $2.804 billion to $2.904 billion, a growth of 15.0% to 19.2% compared to the same period last year.
Despite these optimistic projections, NIO&#8217;s stock has been under significant pressure in 2024, having plunged more than 45% year-to-date.
Price Action: NIO shares are trading lower by 1.29% to $4.60 at last check Thursday.
Photo via Shutterstock
Read Next:
<ul>
<li><a href="https://www.benzinga.com/tech/24/11/42105079/googles-unlawful-behavior-stifles-market-entry-for-rivals-doj-says-alphabet-must-sell-chrome-to-end-search-monopoly" target="_blank" rel="noreferrer noopener">Target Says Shoppers Wait For &#8216;Deals&#8217; A Day After Rival Walmart Credits Market Gains To Wealthy Households</a></li>
</ul>

Media

What's Going On With NIO Stock Thursday?

STKH

Steakholder Foods shares are trading higher after the company announced that its board of directors approved the purchase of up to $1 million in cryptocurrency as treasury reserve assets.

Once approved, BlackBerry AtHoc will be the first critical event management solution to achieve FedRAMP High Authorization
WATERLOO, ON / ACCESSWIRE / November 21, 2024 / <a href="https://pr.report/4fne">BlackBerry Limited</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BB#NYSE">BB</a>)(TSX:<a class="ticker" href="https://www.benzinga.com/stock/BB#TSX">BB</a>) today announced that <a href="https://pr.report/4fnf">BlackBerry AtHoc&#xAE;</a> is listed as "In Process" to achieve <a href="https://pr.report/4fng">Federal Risk and Authorization Management Program</a> (FedRAMP) High Authorization status from the Joint Authorization Board (JAB). Once approved, BlackBerry AtHoc will be the first critical event management (CEM) solution to be authorized for FedRAMP High.
BlackBerry AtHoc is an interoperable CEM system that is trusted by organizations and used by over 75% of U.S. federal government agencies for crisis communications and incident response. Users can quickly activate incident response plans for critical events, capture real-time information, immediately account for all users and rapidly deploy secure communication to specified groups. For any company or government agency looking at CEM solutions, BlackBerry AtHoc meets the most rigorous security and compliance standards.
FedRAMP High authorization was introduced to secure the government's most sensitive, unclassified data in cloud computing environments, including data that involves the protection of life. It is reserved for the protection of data where the loss of confidentiality, integrity, or availability could be expected to have a severe or catastrophic adverse effect on organizational operations, organizational assets, or individuals. This includes law enforcement and emergency services systems, financial systems, health systems.

TSX:BB

BlackBerry AtHoc "In Process" Finalization For FedRAMP High Authorization; Once Approved, BlackBerry AtHoc Will Be The First Critical Event Management Solution To Achieve FedRAMP High Authorization

Intersocietal Accreditation Commission (IAC)'s release of new standards accepting ultra-low-field MRI technology enables accredited facilities to qualify for reimbursement from the US Centers for Medicare &amp; Medicaid Services (CMS).
Hyperfine, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HYPR#NASDAQ">HYPR</a>), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable magnetic resonance (MR) brain imaging system—the Swoop&#xAE; system—today announced the issuance of new MRI standards by the Intersocietal Accreditation Commission (IAC), a leading CMS-approved accrediting body. The new standards, effective immediately, now include portable MR scanning at the point of care.

HYPR

Hyperfine Swoop Portable MR Brain Imaging System Meets New Standards Recently Issued By CMS-Approved Accrediting Body

Joby Aviation: I'm Bullish Ahead Of Earnings Release But Questions Remain

Blade Air Mobility: Attractive Business, Growth Visibility, And Undervaluation

Blade Air Mobility Q3 2024 Earnings Preview

Here's the major earnings before the open tomorrow

Blade Air Mobility reports Q3 results

Reports Q3 revenue $74.877M, consensus $74.44M. "We reached an important milestone this quarter in our Passenger Business, achieving positive Segme...

Blade Air Mobility reports Q3 EPS (3c), consensus (5c)

Blade Air Mobility, Inc. (BLDE) Q3 2024 Earnings Call Transcript

Blade Air Mobility, Inc. ( ($BLDE) ) has released its Q3 earnings. Here is a breakdown of the information Blade Air Mobility, Inc. presented to its...

Blade Air Mobility Reports Q3 2024 Financial Results

Blade: Transition To Profitability Should Provide Support Going Forward

Virtual Meeting to be held with CEO Wiesenthal and CFO Heyburn on November 25. Published first on TheFly – the ultimate source for real-time, marke...

Blade Air Mobility management to meet virtually with Lake Street

ACTG

AGEN

AMTX

AUTL

AXSM

BAYZF

BIOX

BITF

BLDEW

BWAY

BXSL

CAMT

CBAT

CCLD

CGEN

CRON

CVAC

DAVA

EADSF

EADSY

EVGO

FLNG

FOUR

GENI

GLNG

HUYA

KOPN

LEGN

LFWD

MIRM

NSPR

NVAX

ONON

PLUG

RAIL

RGEN

RGTI

ROIV

SATS

SDGR

SFTBY

SHLS

SHOP

SLVM

SOHO

SOHU

SPHR

STLA

TIGR

UBER

VERI

ZLAB

Press Releases

Blade Air Mobility to present at the Jefferies eVTOL / AAM Summit

SHARE Series Live at NYSE

Blade Air Mobility to Present at SHARE Series Event

Blade Air Mobility Announces Date for Second Quarter Ended June 30, 2024 Earnings Release Conference Call

Blade Air Mobility Announces Opening of Investor Q&A Platform Ahead of its Release of Fiscal Second Quarter 2024 Financial Results

Earnings

Blade Air Mobility Announces Second Quarter 2024 Results

BLADE extends its airline agreements through its partnership with Qatar Airways, allowing passengers to fly from anywhere in the world straight to Monaco on a single ticket

Blade Air Mobility to Announce Third Quarter 2024 Financial Results on November 12, 2024

Blade Air Mobility Announces Opening of Investor Q&A Platform Ahead of its Release of Fiscal Third Quarter 2024 Financial Results

Blade Air Mobility Announces Third Quarter 2024 Results

BRLT

American Airlines Group, Inc. - Common Stock

American Airlines Gr

Allegiant Travel

Alaska Air Gr

Azul S.A. American Depositary Shares (each representing three preferred shares)

Azul

Copa Holdings

Delta Air Lines

flyExclusive

JetBlue Airways Corporation - Common Stock

JetBlue Airways

Joby Aviation

Jet AI

LATAM Airlines Group S.A. American Depositary Shares (each representing two thousand (2,000) shares of Common Stock)

LATAM Airlines Group

Southwest Airlines

Mesa Air Gr

Ryanair Holdings plc - American Depositary Shares, each representing five Ordinary Shares

Ryanair Hldgs

SkyWest

Sun Country Airlines Holdings, Inc. - Common Stock

Sun Country Airlines

Comments

Blade Air Mobility

Blade Air Mobility (BLDE) 옵션

Blade Air Mobility (NASDAQ:BLDE) 주식, 옵션 체인

뉴스

파트너 / 기고자

벤징가 글로벌